A Novel Exon 19 EGFR mutation in a patient with lung adenocarcinoma: A Case Report and Literature Review

A Novel Exon 19 EGFR mutation in a patient with lung adenocarcinoma: A Case Report and Literature Review

Non-small-cell lung cancer (NSCLC) exemplifies how biomarker-driven therapies can alter the natural course of a disease. Clinically significant mutations in the epidermal growth factor receptor (EGFR) in NSCLC include a spectrum of substitutions, deletions, and insertions, mainly affecting exons 18...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Gutiérrez-Sainz, Rocío Rosas-Alonso, Carlos Rodríguez-Antolín, Carmen Rodríguez-Jiménez, Isabel Esteban Rodríguez, Rafael Peláez, Oliver Higuera Gómez, Julia Villamayor, Patricia Cruz-Castellanos, Alberto Peláez-García, Inmaculada Ibáñez de Cáceres, Javier de Castro Carpeño
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Non-small-cell lung cancer (NSCLC)
Epidermal growth factor receptor (EGFR) mutations
novel exon 19 EGFR mutation
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621925000262
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items